Antibodies as Drugs
joint with Computational Design and Modeling of Biomolecules
Scientific Organizers: Pierre Bruhns, Esther Breij and David P. Humphreys
Date: January 30 - February 02, 2022
|InPerson Location: Keystone Resort, Keystone, CO, USA|
|Meeting is available as a Livestream, click register button below for more details|
|Meeting is available to view On Demand, click register button below for more details|
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
Therapeutic antibodies continue to largely populate the list of top biologic drugs. They revolutionize the treatment of pathologies falling into major disease areas, which include cancer, chronic inflammatory diseases, allergy and infectious diseases. As more antibodies are being tested to treat an expanding number of pathologies, there has also been a concomitant increase in the frequency of resistance and escape mechanisms. Thus, researchers are exploring alternative concepts to prevent unresponsiveness or treat resistant patients. Therefore, not only are new methodological and technological advances being developed, paradigm-shifting concepts are being developed in order to face these challenges. This conference in the Keystone Symposia series on Antibodies as Drugs aims to present the state-of-the-art in antibody therapeutics, repertoires and deep learning, bispecific antibodies and engineering. This conference will provide a forum for extensive interactions between investigators from both industry and academia. Goals of this conference include discussion of recent breakthroughs in identifying therapeutics from patients, understanding vaccination and mode of delivery, modalities for half-life extensions and involvement of complement in antibody mode of action. It is anticipated that research in the field will showcase the rise of bispecific antibodies and highlight the technologies to develop them, improve their functionalities, and boost clinical efficacies, particularly in immune-oncology.
Global Health Award Deadline: January 10 2022 details
Scholarship Deadline: October 14 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
All those submitting an abstract should plan to attend in-person to ensure extensive interaction opportunities. At this time we recognize that a small percentage of submitters may be unable to travel due to border crossing restrictions and/or institutional travel bans. If these restrictions are still in place during the meeting, permissions for remote presentations will be given for the exceptional circumstances listed above.
NOTE: In the event that your abstract isn't selected for a short talk and you're not able to travel the abstract fee is nonrefundable. All paid abstracts will be included in the meeting app and meeting materials available online.
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI154980-01
Funding for this conference was made possible (in part) by 1R13AI154980-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.